Peno L, De Silanes De Miguel C, De Torres L, Ortiz M, Moreno M, Rodeno B
Basic Clin Neurosci. 2023; 14(2):311-316.
PMID: 38107523
PMC: 10719973.
DOI: 10.32598/bcn.2021.1893.1.
Nabizadeh F, Balabandian M, Rostami M, Owji M, Sahraian M, Bidadian M
Curr J Neurol. 2023; 21(3):144-150.
PMID: 38011341
PMC: 10082961.
DOI: 10.18502/cjn.v21i3.11106.
Sabanagic-Hajric S, Memic-Serdarevic A, Sulejmanpasic G, Salihovic-Besirovic D, Kurtovic A, Bajramagic N
Mater Sociomed. 2023; 35(1):23-27.
PMID: 37095882
PMC: 10122534.
DOI: 10.5455/msm.2023.35.23-27.
Barateiro A, Barros C, Pinto M, Ribeiro A, Alberro A, Fernandes A
Front Mol Neurosci. 2023; 16:1087745.
PMID: 36818652
PMC: 9937661.
DOI: 10.3389/fnmol.2023.1087745.
Tekin S, Bir L, Oncel C, Unluturk Z, Aydin E
Neurosciences (Riyadh). 2022; 27(4):251-256.
PMID: 36252970
PMC: 9749572.
DOI: 10.17712/nsj.2022.4.20220019.
Blood Neurofilament Light in Progressive Multiple Sclerosis: Post Hoc Analysis of 2 Randomized Controlled Trials.
Leppert D, Kropshofer H, Haring D, Dahlke F, Patil A, Meinert R
Neurology. 2022; 98(21):e2120-e2131.
PMID: 35379762
PMC: 10263182.
DOI: 10.1212/WNL.0000000000200258.
The Possible Direct Correlation between Cognitive Impairment and Fear of Catching COVID-19 among Patients with Multiple Sclerosis.
Saeedi R, Rezaeimanesh N, Sahraian M, Naser Moghadasi A
Iran J Psychiatry. 2021; 16(3):336-342.
PMID: 34616468
PMC: 8452838.
DOI: 10.18502/ijps.v16i3.6260.
Cognition and disease characteristics in adult onset versus late onset multiple sclerosis.
Butler Pagnotti R, Hua L, Miller J
Mult Scler. 2021; 28(6):933-941.
PMID: 34410177
PMC: 9199429.
DOI: 10.1177/13524585211039112.
Validity and reliability of the Georgian-language brief international cognitive assessment for multiple sclerosis (BICAMS).
Botchorishvili N, Shiukashvili N, Mikeladze N, Dzagnidze A, Mikava N, Tighashvili M
BMC Neurol. 2021; 21(1):218.
PMID: 34107913
PMC: 8188683.
DOI: 10.1186/s12883-021-02249-x.
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire.
Migliore S, Landi D, Proietti F, DAurizio G, Squitieri F, Mataluni G
Neurol Sci. 2021; 42(11):4583-4589.
PMID: 33651198
DOI: 10.1007/s10072-021-05141-1.
Cognitive Disorders in Patients with Multiple Sclerosis.
Sehanovic A, Smajlovic D, Tupkovic E, Ibrahimagic O, Kunic S, Dostovic Z
Mater Sociomed. 2021; 32(3):191-195.
PMID: 33424448
PMC: 7780783.
DOI: 10.5455/msm.2020.32.191-195.
Treatment and management of cognitive dysfunction in patients with multiple sclerosis.
DeLuca J, Chiaravalloti N, Sandroff B
Nat Rev Neurol. 2020; 16(6):319-332.
PMID: 32372033
DOI: 10.1038/s41582-020-0355-1.
Multiple challenges for people after transitioning to secondary progressive multiple sclerosis: a qualitative study.
Bogosian A, Morgan M, Moss-Morris R
BMJ Open. 2019; 9(3):e026421.
PMID: 30852548
PMC: 6429969.
DOI: 10.1136/bmjopen-2018-026421.
Enhanced GABAergic Tonic Inhibition Reduces Intrinsic Excitability of Hippocampal CA1 Pyramidal Cells in Experimental Autoimmune Encephalomyelitis.
Kammel L, Wei W, Jami S, Voskuhl R, ODell T
Neuroscience. 2018; 395:89-100.
PMID: 30447391
PMC: 6289277.
DOI: 10.1016/j.neuroscience.2018.11.003.
Cognitive and Language Deficits in Multiple Sclerosis: Comparison of Relapsing Remitting and Secondary Progressive Subtypes.
Ntoskou K, Messinis L, Nasios G, Martzoukou M, Makris G, Panagiotopoulos E
Open Neurol J. 2018; 12:19-30.
PMID: 29576812
PMC: 5850485.
DOI: 10.2174/1874205X01812010019.
A structural MRI study of cholinergic pathways and cognition in multiple sclerosis.
Kimura Y, Sato N, Ota M, Maikusa N, Maekawa T, Sone D
eNeurologicalSci. 2017; 8:11-16.
PMID: 29260029
PMC: 5730909.
DOI: 10.1016/j.ensci.2017.06.008.
Functional Components of Cognitive Impairment in Multiple Sclerosis: A Cross-Sectional Investigation.
Matias-Guiu J, Cortes-Martinez A, Valles-Salgado M, Oreja-Guevara C, Pytel V, Montero P
Front Neurol. 2017; 8:643.
PMID: 29234305
PMC: 5712315.
DOI: 10.3389/fneur.2017.00643.
Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability.
Migliore S, Ghazaryan A, Simonelli I, Pasqualetti P, Squitieri F, Curcio G
Behav Neurol. 2017; 2017:7404289.
PMID: 28912625
PMC: 5574272.
DOI: 10.1155/2017/7404289.
Gulf War illness (GWI) as a neuroimmune disease.
Georgopoulos A, James L, Carpenter A, Engdahl B, Leuthold A, Lewis S
Exp Brain Res. 2017; 235(10):3217-3225.
PMID: 28762055
DOI: 10.1007/s00221-017-5050-0.
Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory.
Solaro C, Trabucco E, Signori A, Martinelli V, Radaelli M, Centonze D
PLoS One. 2016; 11(9):e0160261.
PMID: 27632167
PMC: 5025048.
DOI: 10.1371/journal.pone.0160261.